Modulation of Cancer Networks through Protein Degradation, DNA Repair Inhibition, and Quantitative Interactomics
Abstract
Recent innovations in oncology drug discovery reveal a convergent strategy built on biological dependency, protein fate control, and quantitative network analysis. Epigenetic protein degradation enables durable transcriptional rewiring, helicase inhibition exploits synthetic-lethal DNA repair vulnerabilities, and DNA-barcoded interactomics quantifies higher-order protein complexes. Together, these advances redefine precision oncology as a system-level discipline driven by context, modality, and measurable biological consequence.
Fields of Study & Subjects
Protein Degradation and Inhibitors
Cancer-related Molecular Pathways
Chromatin Remodeling and Cancer
Publication details
- Journal / source
- ACS Medicinal Chemistry Letters
- Volume
- 17
- Issue
- 3
- Pages
- 628–630
- Publication date
- 23 February 2026
- Language
- EN